Evidence map›Paper›PMID 40356399›Full record

ArticleInterventional neuroradiology : journal of peritherapeutic neuroradiology, surgical procedures and related neurosciences2025

Effect of race on procedural and clinical outcomes in middle meningeal artery embolization for primary and adjunctive treatment of chronic subdural hematoma.

Santiago Gomez-Paz, Mohamed M Salem, Cordell Baker, Okkes Kuybu, Georgios S Sioutas, Kate T Carroll, Mira Salih, Adam A Dmytriw, Jane Khalife, William Smith and 20 more

Abstract read
In one paragraph

Article in Interventional neuroradiology : journal of peritherapeutic neuroradiology, surgical procedures and related neurosciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

30 authors.

Santiago Gomez-PazDepartment of Neurosurgery, Clinical Neurosciences Center, University of Utah, Salt Lake City, UT, USA.ORCID 0000-0003-2283-3612
Mohamed M SalemDepartment of Neurosurgery, Hospital of the University of Pennsylvania, Penn Medicine, Philadelphia, PA, USA.
Cordell BakerDepartment of Neurosurgery, Clinical Neurosciences Center, University of Utah, Salt Lake City, UT, USA.
Okkes KuybuDepartment of Neurosurgery, University of Pittsburgh, Pittsburgh, PA, USA.ORCID 0000-0003-0655-5755
Georgios S SioutasDepartment of Neurosurgery, Hospital of the University of Pennsylvania, Penn Medicine, Philadelphia, PA, USA.ORCID 0000-0003-3937-4029
Kate T CarrollDepartment of Neurosurgery, University of Washington, Seattle, WA, USA.
Mira SalihDivision of Neurosurgery, Beth Israel Deaconess Medical Center, Harvard Teaching Hospital, Boston, MA, USA.
Adam A DmytriwNeuroendovascular Program, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.ORCID 0000-0003-0131-5699
Jane KhalifeDepartment of Neurosurgery, Cooper University Health Care, Camden, NJ, USA.ORCID 0000-0003-3662-3886
William SmithNeuroendovascular Program, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.
Diego Alejandro Ortega MorenoDivision of Neurosurgery, Department of Surgery, St Michael's Hospital, University of Toronto, Toronto, Ontario, Canada.ORCID 0000-0002-7295-1038
Robert W RegenhardtNeuroendovascular Program, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.ORCID 0000-0003-2958-3484
Nicole M CancelliereDivision of Neurosurgery, Department of Surgery, St Michael's Hospital, University of Toronto, Toronto, Ontario, Canada.
Alejandro M SpiottaDepartment of Neurosurgery, Medical University of South Carolina, Charleston, SC, USA.ORCID 0000-0002-7142-5538
Omar TanweerDepartment of Neurosurgery, Baylor College of Medicine, Houston, TX, USA.
Christopher J StapletonNeuroendovascular Program, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.ORCID 0000-0003-4805-0093
Michael LangDepartment of Neurosurgery, University of Pittsburgh, Pittsburgh, PA, USA.
Vitor M PereiraDivision of Neurosurgery, Department of Surgery, St Michael's Hospital, University of Toronto, Toronto, Ontario, Canada.
Aman B PatelNeuroendovascular Program, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.
Adnan H SiddiquiDepartment of Neurosurgery, University at Buffalo, Buffalo, NY, USA.ORCID 0000-0002-9519-0059
Elad I LevyDepartment of Neurosurgery, University at Buffalo, Buffalo, NY, USA.ORCID 0000-0002-6208-3724
Christopher S OgilvyDivision of Neurosurgery, Beth Israel Deaconess Medical Center, Harvard Teaching Hospital, Boston, MA, USA.
Daniel TonettiDepartment of Neurosurgery, Cooper University Health Care, Camden, NJ, USA.ORCID 0000-0002-9258-1820
Ajith J ThomasDepartment of Neurosurgery, Cooper University Health Care, Camden, NJ, USA.
Visish M SrinivasanDepartment of Neurosurgery, Hospital of the University of Pennsylvania, Penn Medicine, Philadelphia, PA, USA.ORCID 0000-0001-7673-6805
Brian T JankowitzJFK New Jersey Neuroscience Institute, Edison, NJ, USA.ORCID 0000-0001-9306-0763
Michael R LevittDepartment of Neurosurgery, University of Washington, Seattle, WA, USA.ORCID 0000-0003-3612-3347
Bradley A GrossDepartment of Neurosurgery, University of Pittsburgh, Pittsburgh, PA, USA.
Jan-Karl BurkhardtDepartment of Neurosurgery, Hospital of the University of Pennsylvania, Penn Medicine, Philadelphia, PA, USA.
Ramesh GrandhiDepartment of Neurosurgery, Clinical Neurosciences Center, University of Utah, Salt Lake City, UT, USA.ORCID 0000-0001-9000-6083

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

BackgroundWe investigated racial disparities in radiologic and clinical outcomes of patients after middle meningeal artery embolization (MMAE) for chronic subdural hematoma (CSDH) with or without evacuation surgery.MethodsThis multicenter retrospective study includes consecutive patients who underwent MMAE across 11 institutions in North America (10 in the United States and 1 in Canada). Patients were stratified using self-reported racial data. Outcomes of interest were complications, treatment failure/reoperations, resolution of hematoma, and functional independence at last follow-up. Multivariable regression models were used to assess and adjust for relevant confounders.ResultsA total of 557 patients underwent 663 MMAEs, including 323 White (58%), 150 Black (27%), 35 Hispanic (6%), 29 Asian (5%) patients, and 20 patients (4%) self-categorized as other/nondisclosed. The median age (interquartile range) of the cohort was 75 (65-81) years, and 412 (74%) patients were female. Middle meningeal artery embolization was the primary treatment for CSDH for 369 patients (66%) and adjunct treatment for 188 (34%). Black patients had a 51% lower likelihood of reoperation relative to other racial categories (adjusted odds ratio [OR] 0.49; 95% confidence interval [CI] 0.25-0.95,

Indexed as

Chronic subdural hematomahealthcare disparitiesmiddle meningeal artery embolizationracial groups

Identifiers

PMID40356399
PMCPMC12075154

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.